Monograph Details
|
|
Respiratory Tract
> Asthma/COPD
|
|
QVAR |
| Manufacturer |
|
Teva Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Steroid. |
| Generic Name |
|
Beclomethasone dipropionate 40 micrograms/inh, 80 micrograms/inh; metered dose inhaler; CFC-free. |
| Indications |
|
Maintenance treatment of asthma as prophylactic therapy. Asthma requiring systemic corticosteroid therapy, to reduce need for systemic corticosteroids. |
| Children |
|
<5 years: not recommended. 5–11 years: initially 40 micrograms twice daily; max 80 micrograms twice daily. Rinse mouth after use. |
| Adults |
|
Previously on bronchodilators alone: initially 40–80 micrograms twice daily; max 320 micrograms twice daily. Previously on inhaled corticosteroids: initially 40–160 micrograms twice daily; max 320 micrograms twice daily. Rinse mouth after use. |
| Contraindications |
|
Not for treatment of acute attacks. |
| Precautions |
|
Maintain regular regimen. Infections. If exposed to chickenpox or measles, consider anti-infective prophylactic therapy. If adrenal insufficiency exists following systemic corticosteroid therapy, replacement with inhaled corticosteroids may exacerbate symptoms of adrenal insufficiency (eg, lassitude). Monitor for growth suppression in children. Monitor for hypercorticism and HPA axis suppression (if occur discontinue gradually). Transferring from systemic corticosteroids: see literature. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Adverse Reactions |
|
Headache, pharyngitis, rhinitis, pain, oral candidiasis. |
| How Supplied |
|
Inhaler—7.3 g (100 inh) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
